ACUTE LEUKEMIAS 1 Flashcards

1
Q

All pluripotent cells in the bone marrow proliferate into what 2 cells?

A

Myeloid and Lymphoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Proliferate into their mature end cells within the bone marrow

A

Myeloid cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Migrate to the lymphoid organs to complete maturation

A

Lymphoid precusors (T cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

An uncontrolled proliferation of myeloid or lymphoid blasts

A

Acute leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the mechanism that ensures that the cells remain proliferative and never mature so cancer progresses?

A

Cells are blocked at an early stage of differentiation and
have a proliferative advantage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Do acute leukemias metastisize and invade tissues and organs outside of the marrow?

A

Yes,
They can invade BM, blood and extramedullary sites

*They often replace normal haematopoietic cells in the BM, which causes life threatening cytopenias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Arise from multiple genetic mutations, both
unchecked proliferation and abnormal or no maturation

A

Acute leukemias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Most common type of acute leukaemia in adults, with the median age at presentation of 65 years

A

Acute Myeloid Leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Patients are often younger

A

Acute promyelocyte anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Common in children, with peak incidence between ages of 2
and 5 years.

A

Acute Lymphoid Leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name the cell that is not of myeloid origin
A. Erythroblast
B. Basophil
C. Natural killer cell
D. Neutrophil

A

Natural killer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The pathogenic genomic abnormalities in haematopoietic
stem and progenitor cells include:

A
  1. structural cytogenetic abnormalities
  2. mutations
    leading to abnormal proliferative advantage.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Acute leukemia Risk factors

A
  • Chromosomal abnormalities (e.g., Fanconi anaemia, Down
    syndrome etc.)
  • Germline predisposition
  • Drugs (i.e. chemotherapy) or benzene
  • Radiation
  • Other myeloid malignancies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List the symptoms of bone marrow failure

A
  • Anaemia; dyspnoea, palpitations, fatigue, headache etc.
  • Thrombocytopenia; mucocutaneous bleeding (easy bruising, petechiae, epistaxis, bleeding gums, menorrhagia etc.)
  • Neutropenia; infections
  • Tissue infiltration – gingival
    hyperplasia, lymphadenopathy,
    hepatomegaly, splenomegaly,
    CNS, scrotum etc.
  • Joint and bone pain (paediatric
    population) - limping or
    refusing to walk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Death within 30 days of
diagnosis

A

Acute Promyelocytic leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the cause of sudden death following Acute Promyelocytic Leukemia (APL)?

A

Production of pro-coagulant granules by the (APL)»trigger the DIC»Leads to coagulation and clots forming throughout the microvasculature»>Platelets and clotting factors depleted»>Hermorhage and bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

The translocation unique to APL

A

t(15,17)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe how the t(15,17) mutation is derived

A

Involves the PML gene (promyelocytic leukaemia) on chr 15 and the RARa gene (retinoic acid receptor-alpha) on chr 17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is a maturation block?

A

myeloid precursors unable to mature beyond the promyelocyte stage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

A common finding in Acute Myeloid lukemia, which leads to increased blood viscosity

A

Hyperviscosity

*Seen with WBC counts >100 x 109/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe the impact of high, immature leukemic myeloids in the blood

A

Intravascular accumulation of these quickly proliferating cells»increased viscosity of blood»thrombotic complications

22
Q

helpful in making a hyperviscosity diagnosis

A

Fundoscopic examination

23
Q

The PML-RARA fusion gene is the same as which
translocation?
A. t(15;17)
B. t(8;21)
C. t(9;22)
D. t(12;21)

24
Q

Can occur in all ages but has its peak incidence in the 7th
decade (70 yrs)

A

Acute myeloid leukemia

25
Survival expectations remain age-dependent, with a 62% estimated 5-year survival in patients diagnosed under the age of 50 years, 37% in 50–64 years, and only 9·4% in ≥ 65 years
AML
26
An acute leukemia classified according to morphology
AML
27
primarily a disease of childhood, ~75% of cases in children <10 years
ALL
28
An acute leukemia presenting with good prognosis in children, >90% survive without disease in the long term. However, the outcome of older adults (≥40 years) and patients with relapsed or refractory disease remains poor.
ALL
29
Which of the 2 lymphoblastic leukemias is more common? The B or T cell lymphoblastic leukemia?
B cell
30
An acute lymphoblastic leukemia resulting to mediastinal mass
T cell
31
organ involvement quiet seen with this kind of leukemia– splenomegaly, hepatomegaly, LAD, testicular swelling, CNS etc
ALL
32
Techniques or methods to carry out ALL diagnoses
- Clinical history and examination * FBC, differential count and peripheral smear * CXR - lymphadenopathy or an enlarged thymus. * CEU, LFT’s, PT, PTT, LDH, Uric acid etc
33
EXAMPLES OF IMPORTANT GENETIC FEATURES IN ALL
Good prognosis * Hyperdiploidy-> 50 < 66 chromosomes * t(12;21) Bad prognosis * t(9;22) * KMT2A gene rearrangement –11q23
34
The full blood count for an AML
- White cell count – low, high or normal * Haemoglobin – usually low (anaemia) * Platelets – usually low (thrombocytopenia)  typically severe decrease in counts Need to request a differential count, to check WBC composition & neutrophils >>>pancytopenia = neutropenia, anaemia and thrombocytopenia. * Peripheral smear – increase in BLASTS. * Acute leukaemia ≥20% blasts in the blood or BM but......... * Some acute leukaemia with specific genetic abnormalities can be diagnosed with <20% blasts. - Auer rod - AML
35
Specific AML Investigation methods or techniques
- Bone marrow aspirate and trephine biopsy * Flow cytometry * Conventional cytogenetics * FISH analysis * NGS
36
This AML investigation method Uses antibodies directed against surface and cytoplasmic antigens
Flow cytometry
37
An AML investigation method that detects large chromosomal abnormalities. Analysis of the number and structure of chromosomes
CONVENTIONAL CYTOGENETICS
38
Allows analysis of chromosome structure at a molecular level
FISH
39
- Able to detect multiple genetic abnormalities in a single test: * Mutations and translocations. * Diagnostic and prognostic significance.
NXT GENERATION SEQUENCING
40
An Auer rod is seen in which type of acute leukaemia? A. T lymphoblastic leukaemia B. Acute myeloid leukaemia C. B lymphoblastic leukaemia D. Chronic lymphocytic leukaemia
B
41
Which type of abnormality cannot be detected on karyotype? A. Mutation B. Trisomy C. Monosomy D. Translocation
A
42
FACTORS WHICH AFFECT AML PROGNOSIS ON VARIOUS PATIENTS
- Age * Cytogenetic abnormalities * Additional mutations * Response to initial chemotherapy * CNS disease in ALL * Performance status
43
EXAMPLES OF IMPORTANT GENETIC FEATURES IN AML
Good prognosis * t(8;21) * Inversion 16 Bad prognosis * Complex karyotype
44
MANAGEMENT OF THE ACUTE LEUKEMIAS
- Supportive therapy - should be initiated to correct haematologic, metabolic and infectious complications. - transfusions, antibiotics, fluids etc. * Specific therapy * Chemotherapy – systemic and CNS * Allogeneic haemopoietic stem cell transplantation
45
Discuss chemotherapy
- Work by impairing mitosis >>targeting rapidly dividing cells. * They prevent mitosis by various mechanisms including damaging DNA. * Familiarity with the agents used is required to prevent or anticipate and treat toxicities timeously. * Many side effects are due to damage to normal cells that divide rapidly e.g. BM, digestive tract and hair follicles.
46
Name the side effects of chemotherapy
- Short term; hair loss, immunosuppression, cytopenias, nausea and vomiting, skin rash, mucositis etc. Long term: - Infertility – consider fertility preservation prior to chemotherapy. - Secondary malignancies
46
Basic Principles of Treatment
the goal is to completely eradicate blast cells through intensive chemotherapy (induction phase) Patient on chemo are at risk of infections and chemotherapy side effects Consolidation phase – for patients in complete remission (CR) to eliminate residual leukaemic blasts and prevent relapse. - better tolerated than induction therapy Maintenance – to maintain remission, for up to 2 to 3 years. CNS directed therapy – in ALL, to prevent and treat CNS disease. -given at all the phases of therapy.
47
To see with response to chemotherapy
- Complete remission – absence of extra-medullary disease (no LAD, hepatomegaly, splenomegaly etc.) - absolute neutrophil count > 1 x 109/L - platelet count >100 x 109 /L - <5% blasts in the bone marrow
48
APL management
- ATRA (All Trans Retinoic Acid) is required. * Helps with maturation of promyelocytes to granulocytes  reverses the coagulopathy associated with APL. * Should be given ASAP if any suspicion of APL – this is a medical emergency.
49
50